IMMUNOMEDICS INC (IMMU)

Overview Price 3.70 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $3.70 Daily Range $0.00 - $0.00 52-Week Range $2.85 - $4.47 Volume 0 Immunomedics Inc. is a New Jersey-based biopharmaceutical company focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. They have developed a number of advanced proprietary technologies that allow us to create humanized antibodies that can be used either alone in unlabeled or naked form, or conjugated with radioactive isotopes, chemotherapeutics or toxins, in each case to create highly targeted agents. Using these technologies, the company have built a pipeline of therapeutic product candidates that utilize several different mechanisms of action. They have recently licensed its lead product candidate, epratuzumab, to UCB, S.A. for the treatment of all autoimmune disease indications worldwide. Other Resources for IMMU Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: UCB-Astellas Collaborate February 7, 2012 Zacks Blog: CNS Cure Priority for UCB & Partner January 13, 2012 Zacks Blog: UCB-Immunomedics Restructure Deal January 5, 2012 Zacks Blog: Revs Rise at Immunomedics in Q4 August 25, 2011 Zacks Blog: UCB Faces Setback March 18, 2011 Immunomedics Inc. is a New Jersey-based biopharmaceutical company focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. They have developed a number of advanced proprietary technologies that allow us to create humanized antibodies that can be used either alone in unlabeled or `naked` form, or conjugated with radioactive isotopes, chemotherapeutics or toxins, in each case to create highly targeted agents. Using these technologies, the company have built a pipeline of therapeutic product candidates that utilize several different mechanisms of action. They have recently licensed its lead product candidate, epratuzumab, to UCB, S.A. for the treatment of all autoimmune disease indications worldwide.   Brokerage Analyst Recommendations 5 Brokerage Firms Covering IMMU   Strong Buy 5 Buy 0 Hold 0 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1   IMMU Ratings: BUY  SELL  HOLD IMMU Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 15 Buy 0 Sell   Top Buy Analysis BUY: IMMU Company: IMMUNOMEDICS INC. Points: 67.73 Start Price: $1.59 Start Date: 12/01/2008 5:54 PM Eversar P&P Score: 95.47 Recs: Unusually High Option Volume at $2.5 for 1/09 Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
PandPBlog	0.00	10/19/10	P&P Podcast for October 19, 2010	0
zantriocom	0.00	09/01/09	Zantrio.com Stock Picks for September 1, 2009	0
Zacks_Analysts	0.00	02/07/12	UCB-Astellas Collaborate - Analyst Blog	0
Zacks_Analysts	0.00	01/13/12	CNS Cure Priority for UCB & Partner - Analyst Blog	0
Zacks_Analysts	0.00	01/05/12	UCB-Immunomedics Restructure Deal - Analyst Blog	0
Zacks_Analysts	0.00	08/25/11	Revs Rise at Immunomedics in Q4 - Analyst Blog	0
Zacks_Analysts	0.00	03/18/11	UCB Faces Setback - Analyst Blog	0
Zacks_Analysts	0.00	01/12/11	UCB's Progress On-Track - Analyst Blog	0
Zacks_Analysts	0.00	12/15/10	UCB Commences Patient Enrolment - Analyst Blog	0
Zacks_Analysts	0.00	06/22/10	Zacks Analyst Blog Highlights: Immunomedics, Human Genome, GlaxoSmithKline, CNOOC and Devon Energy - Press Releases	0

Pages: [ 1 ]  2  >>

Commentary

BUY: IMMUNOMEDICS INC. (IMMU) Start Price: $3.78 Points: -8.48 Created: 06/16/2011 uptrend Comments: 2 | Comment frankbean Recs:

BUY: IMMUNOMEDICS INC. (IMMU) Start Price: $3.21 Points: -5.64 Created: 01/03/2010 Profitable company, ROE 227% Comments: 0 | Comment HappySmile Recs:

BUY: IMMUNOMEDICS INC. (IMMU) Start Price: $1.59 Points: +67.73 Created: 12/01/2008 Unusually High Option Volume at $2.5 for 1/09 Comments: 0 | Comment Eversar Recs:

BUY: IMMUNOMEDICS INC. (IMMU) Start Price: $4.20 Points: -30.63 Created: 01/12/2010 Comments: 0 | Comment raldworth Recs:

BUY: IMMUNOMEDICS INC. (IMMU) Start Price: $2.98 Points: +32.42 Created: 01/01/2008 Comments: 0 | Comment BluePanda Recs:

BUY: IMMUNOMEDICS INC. (IMMU) Start Price: $3.03 Points: +30.36 Created: 01/01/2008 Comments: 0 | Comment bigermac Recs:

BUY: IMMUNOMEDICS INC. (IMMU) Start Price: $2.88 Points: +36.74 Created: 01/01/2008 Comments: 0 | Comment dmkap Recs:

BUY: IMMUNOMEDICS INC. (IMMU) Start Price: $2.71 Points: +44.82 Created: 01/01/2008 Comments: 0 | Comment beeegmoni Recs:

BUY: IMMUNOMEDICS INC. (IMMU) Start Price: $4.20 Points: -3.74 Created: 01/01/2008 Comments: 0 | Comment mlkrgr Recs:

BUY: IMMUNOMEDICS INC. (IMMU) Start Price: $4.80 Points: -14.79 Created: 01/01/2008 Comments: 0 | Comment dlovesupreme Recs:

Pages: [ 1 ]  2  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
frankbean	1.96	BUY	Three to Six Months	06/16/2011	$3.78	$3.71 (-1.85%)	-1.85%	+6.63%	-8.48	view close
raldworth	3.11	BUY	One to Three Months	01/12/2010	$4.20	$3.71 (-1.85%)	-11.67%	+18.96%	-30.63
HappySmile	0.52	BUY	Six Months to a Year	01/03/2010	$3.21	$3.71 (-1.85%)	+15.58%	+21.22%	-5.64	view close
Eversar	95.47	BUY	One to Three Months	12/01/2008	$1.59	$3.71 (-1.85%)	+133.33%	+65.60%	+67.73	view close
BluePanda	54.60	BUY	Six Months to a Year	01/01/2008	$2.98	$3.71 (-1.85%)	+24.50%	-7.92%	+32.42
bigermac	45.76	BUY	Six Months to a Year	01/01/2008	$3.03	$3.71 (-1.85%)	+22.44%	-7.92%	+30.36
dmkap	21.03	BUY	Six Months to a Year	01/01/2008	$2.88	$3.71 (-1.85%)	+28.82%	-7.92%	+36.74
beeegmoni		BUY	Six Months to a Year	01/01/2008	$2.71	$3.71 (-1.85%)	+36.90%	-7.92%	+44.82
mlkrgr	57.55	BUY	Six Months to a Year	01/01/2008	$4.20	$3.71 (-1.85%)	-11.67%	-7.92%	-3.74
dlovesupreme	60.96	BUY	Six Months to a Year	01/01/2008	$4.80	$3.71 (-1.85%)	-22.71%	-7.92%	-14.79

Pages: [ 1 ]  2  >>